In two large-scale trials, Compass Pathways' proprietary form of psilocybin improved people's depression symptoms better than controls.
The FDA has expanded clearance for an accelerated treatment protocol for the noninvasive Deep Transcranial Magnetic Stimulation (Deep TMS, BrainsWay) system for depressive episodes and anxiety ...
Myriad Genetics, Inc., a leader in molecular diagnostic testing and precision medicine, today announced a post-hoc analysis of the Precision Medicine in Mental Health Care (PRIME) study showed that ...
Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, ...
PsyPost on MSN
Persistent depression linked to resistance in processing positive information about treatment
A study comparing individuals with persistent depressive disorder to those with episodic major depressive disorder found that those with persistent depression had lower treatment expectations. These ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...
Major depressive disorder is linked to Th2 immune dysregulation similar to atopic dermatitis. Could dupilumab offer a new ...
Findings provide rationale for targeted strategy in psychiatry that may lead to new personalized treatments for major depressive disorder and other conditions ...
A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major depressive disorder after analyzing a short WhatsApp audio recording where ...
A large review adds weight to an old idea: movement can help ease depression. Here’s how to think about exercise as part of treatment and recovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results